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Abstract
Purpose—To explore the views of university-based investigators conducting genetic research
with human specimens regarding ownership and retention of specimens, and knowledge of related
institutional review board and university policies.
Methods—Data were collected in three phases: a qualitative pilot study of 14 investigators; a
web-based survey taken by 80 investigators; and follow-up, in-depth interviews with 12 survey
respondents.
Results—Investigators named a variety of single or multiple owners of human specimens and
often expressed confusion regarding specimen ownership. Most associated ownership with rights
to control, and responsibilities to maintain, specimens. Investigators viewed specimens as
“precious” resources whose value could be increased through long-term or infinite retention,
particularly in light of anticipated technological advances in genome science. Their views on
ownership and retention were shaped by perceptions of institutional review board policies as
immortalized in subject informed consent documents, rather than knowledge of actual policies.
Conclusion—Long-term retention of human specimens makes confusion about ownership
particularly problematic. Given findings that investigators’ views on ownership and retention are
largely guided by their perception of university policies, the need for clear, consistent policies at
the institution level is urgent.
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Millions of human biological specimens are acquired and stored in the United States each
year for research purposes.1 This impetus to acquire and store specimens for long periods of
Copyright © American College of Medical Genetics.
R. Jean Cadigan, PhD, Department of Social Medicine, CB #7240, University of North Carolina, Chapel Hill, NC 27599-7240.
jean_cadigan@med.unc.edu.
Disclosure: The authors declare no conflict of interest.
NIH Public Access
Author Manuscript
Genet Med. Author manuscript; available in PMC 2012 June 28.
Published in final edited form as:













time, sometimes indefinitely, for future research use raises questions about control and
ownership of the samples. In addition, the Bayh-Dole Act of 1980 permitted universities to
financially benefit from federally funded research and, thus, imbued biologic specimens
collected for scientific purposes with potential economic value. Once specimens are
perceived as scientifically and economically valuable, interest grows in their ownership.
Property law provides the conventional legal construct for ownership, permitting owners to
use their property as they see fit (save some agreed-upon prohibitions intended to protect
others). Once ownership is recognized, rights and responsibilities related to the property can
be established. However, apart from the federal regulations protecting human subjects and
exempting from protection some deidentified samples,2 little national or state law oversees
the creation and use of specimen collections retained for research use for long periods of
time (hereafter “biobanks”). Instead, researchers and institutions across the country develop
biobanking practices and address concerns with little unifying guidance. As a result,
attention is drawn to specimen ownership only when controversy arises, such as when a
researcher wishes to move “his” collection to another university3 or when a bewildered
family learns that their long-dead loved one “lives on” in an immortal cell line (HeLa)
created without their knowledge.4
Given scant guidance, scholars and policy makers have turned to court opinions to
understand how control and ownership of collected samples may inform their use in
research.5 A small collection of case law has determined that samples are controlled and
owned not by those who contributed them but by researchers or their institutions.6–8 The
cases of Moore v. Regents of the University of California and Greenberg v. Miami
Children’s Hospital denied specimen contributors intellectual property rights in
developments that stem from uses of their samples. Washington University v. Catalona used
the frame of institutional ownership to prohibit the researcher from moving the collection to
another institution and denied subjects some aspects of control over their individual
specimens in finding no right for them to have their specimens transferred to another
institution. Taken together, the cases do not offer clear guidance; they are consistent only in
their denial of a right claimed by individuals who contributed samples. In a more recent
case,9,10 favorable terms of settlement for tissue contributors may signal a change in how
subject rights are framed and protected. However, at this time, investigators and institutions
interested in specimen collections conduct their research in an uncertain policy
environment.5
The ethics literature on biobanking has identified ownership as an important issue,11 but
despite researchers’ central role in collection and storage, their views and practices
regarding ownership and long-term retention of specimens have rarely been examined
empirically. Only Capron and colleagues12 have directly explored researchers’ views of
ownership of genetic samples and data. Using hypothetical scenarios, 42 international
experts engaged in operating, policy making, or conducting research using a biobank were
surveyed and found to have “highly divergent and somewhat confused” views.12
Nonresearchers’ perceptions of ownership are beginning to be explored, including those of
people whose samples are used in research13 and institutional review board (IRB) chairs.14
Quite a number of people have written nonempirical articles on ownership.5,15–24
In this study, we report on three interrelated studies of university investigators who conduct
genetic research on human specimens, examining their perceptions of specimen ownership,
their intentions regarding retention of specimens after study completion, and their
knowledge of institutional policies related to ownership and retention. This study contributes
to an emerging empirical literature on researchers’ perceptions related to ethics in research
on human biological specimens and biobanking.
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We collected data in three phases (Fig. 1). We began with (1) a qualitative pilot study of
researchers’ perceptions of ownership of genetic samples conducted in 2006 by several of
the authors. Using findings from these interviews, along with an extensive review of the
literature on the ethical, legal, and social implications of biobanking, we developed and
fielded (2) a web-based survey in 2009 with a larger sample for quantitative analysis. To
further explore findings from the web survey, we conducted (3) follow-up interviews with a
subset of survey respondents in 2010. All study segments were approved by a university
IRB. Verbal consent was obtained from all participants in both the pilot interviews and the
follow-up interviews; written consent was waived for the web survey.
Participants
All participants were engaged in genetic research using human specimens at a large
southeastern university; although some participants were geneticists, many were from other
scientific disciplines. Potential participants in the initial qualitative study on perceptions of
ownership (Pilot Interviews) were identified through the National Institutes of Health CRISP
database and University department websites as principal investigators on grants for which
they collected human specimens for DNA analysis, and these participants were recruited for
the study through a personal email.
Participants in the anonymous web-based survey were recruited by an email to a listserv for
all University faculty. As is typical for listserv-based recruitment, we do not know the
number of people who received the email; and in the case of this survey, it is impossible to
know the total number of researchers engaged in human genetic studies. One hundred
ninety-eight researchers entered the web survey. Of these, 102 screened ineligible because
they answered “no” to the first question: “Have you ever conducted genetic research using
human specimens, at [University] or elsewhere?” An additional 16 were dropped because of
substantial missing data. A total of 80 respondents completed the survey.
Twenty-six of the 80 who completed the web-based survey provided their contact
information indicating they were willing to be recontacted for a follow-up interview. Twelve
completed an interview; the other 14 were lost to follow-up or declined.
Procedures
Data for the pilot study were collected during June to October 2006. The web survey was
accessible and data were collected from April to June 2009, and the follow-up interviews
were conducted from February to April 2010.
Most interviews for the pilot study and follow-up interviews to the web survey were
conducted in person; four were conducted by telephone to accommodate respondents.
Interviews were conducted by individual coauthors, lasted about 45 minutes, and were
digitally recorded and transcribed. The web-based survey was developed and fielded using
Qualtrics software25 and pilot tested to ensure functionality. Data from eligible respondents
were transferred to Stata 1026 to facilitate data management and analysis.
Measures
The pilot interviews explored investigators’ experiences conducting research studies (with
particular emphasis on their currently funded studies), how and under what circumstances
investigators gain access to specimens and related data, and the rights and responsibilities of
diverse stakeholders. Questions about ownership also included experiences sharing and
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loaning specimens and views on what would happen if respondents were to leave the
University or leave science. Investigators were also asked about their understanding of
policies governing specimen use.
The web-based survey examined beliefs and practices related to biospecimen storage and
use with a larger sample of investigators. The survey asked respondents to consider one
genetic research study they were currently conducting or had conducted in the past. Survey
questions addressed the samples used in that focal study, including queries about the number
of specimens, how they were acquired, where and for how long they were stored and
investigators’ perceptions of who owned the specimens and data; the survey also gathered
background information about the respondents.
The follow-up interviews explored findings from the web survey by examining three topics
in detail. Again focusing on their experiences with one study, respondents were asked to
describe underlying decision-making processes regarding retention; to consider the meaning
of ownership and under what circumstances it might matter; and to address any external
policies that could affect ownership or retention of specimens.
Data analysis
Data analysis took place in three stages, corresponding to the three phases of this project.
First, using conventional content analysis,27 four of the authors examined all pilot study
transcripts and through an iterative, collaborative process, developed codes to capture
segments of the text pertaining to how investigators view the specimens, their perceptions of
ownership of the specimens, and their understanding of policies related to the specimens.
Second, results from the web survey were analyzed using simple descriptive statistics.
Finally, follow-up interview transcripts were analyzed using conventional content
analysis,27 led by the first author, who had also participated in analysis of the pilot study
interviews. The first author read each transcript multiple times, kept written notes to record
new insights and questions, and debriefed with coauthors about early findings. The first
author tagged material relevant to broad coding categories (ownership, storage, and policy)
throughout the interview, then coded for subtopics relevant to research questions (e.g., for
ownership of samples: who owns, what it means to own). All findings were discussed with
coauthors familiar with pilot interviews, web survey, or follow-up interviews, and coding
was refined in an iterative process.
RESULTS
Participant characteristics
Table 1 presents data on participants within each study. Although all participants in the
follow-up interviews were necessarily participants in the web survey, we do not know
whether any of the participants in the pilot interviews also participated in the anonymous
web survey. The majority of all respondents held MD or PhD degrees, or both. Database
size reflected different stages and methods of data acquisition, ranging from 4 to 185,000
specimens from individual donors. The distribution was positively skewed with a few very
large databases; the average was 3,985 and the median 250 (n = 65).
Ownership
Uncertainty and lack of consensus about ownership—In the pilot interviews,
investigators described four parties—the investigator, the funder, the University, and the
specimen contributor—as having ownership or an ownership-related right, although
investigators named themselves most often. In some cases, ideas of ownership were
informed by an intuitive, proprietary sense of individualized ownership, crystallized by
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investigator comments such as “I assume I would take my samples with me if I left the
University” and “I’m sure the University couldn’t sell my samples.”
Uncertainty about ownership was also apparent when investigators identified a single owner
and then added others as they formulated their responses:
“Who owns the samples? That’s a good question. If somebody told me they wanted
them back, I would probably give them to them. So, in some sense I suppose
they’re on loan from the body I got them from. Unless they’re dead. I mean
otherwise I think, short of that I guess, I would be the next in line of ownership.”
Herein, the investigator perceives the sample contributor as holding the primary ownership
claim. However, when asked later in the interview, “Does it mean you own [the sample] if
you can loan it?” the same investigator offered a different view: “Well, I can loan it. Yeah. I
think that I own it pretty much. I am the ultimate authority determining the fate of those
entities of data and biological samples.” Uncertainty was evident not only from this
respondent’s suggestion that both investigators and specimen contributors have claims of
ownership but also because taken together, the respondent’s answers demonstrate a conflict
as to whether and how one claim might subordinate another.
Even with the limitations of the small sample size of the pilot interview study, it was striking
that something as essential as the ownership of human specimens was understood differently
by these researchers. How widespread was this apparent uncertainty about ownership? Was
it common to perceive multiple owners for their specimen collections? To investigate these
issues further, we included a question about ownership of specimens in our web survey of
the larger sample at the same university (Fig. 2).
Survey results confirm the finding from the pilot interviews regarding confusion about
ownership. Table 2 presents results from the web survey and the follow-up interviews. Half
of survey respondents identified single owners for the specimens, more than one third
identified multiple owners, and another 11% were not sure who owned them. Of those who
identified multiple owners in the survey (n = 28; see Table 3), the most popular
combinations were Investigator & Donor, Investigator & Funder, and Investigator &
University. Thirteen respondents cited three or more owners. Although half the web survey
sample (n = 40) identified a single owner, only 13 chose the university where the research is
conducted—the owner typically recognized in case law and by University policy. Thirteen
identified a single investigator as sole owner (usually the principal investigator) and eight
identified the specimen contributors (“donors” in the survey choices) as sole owners.
Reasoning about ownership—In the follow-up interviews, some respondents said they
consulted their study consent form to see what, if anything, it said regarding ownership.
Others reported that they based their answers on who they thought ought to own the
specimens, for example, the individual because the specimen came from his/her body or the
principal investigator because s/he collected them, rather than referring to University
policies or legal precedence. As in the pilot interviews, some respondents also changed their
minds during the interview. Thus, the follow-up interviews further confirmed inconsistency
and lack of consensus about specimen ownership.
Sorting out rights, responsibilities, and ownership—In both the pilot and follow-up
interviews, respondents discussed rights and responsibilities associated with the specimens.
Some investigators equated ownership of the specimens with the right to control them,
which, depending on who or what the investigator believed to own the specimens, included
(1) the right to withdraw the specimens, (2) the ability to conduct future research using
them, (3) the right to distribute and manage them, (4) the authority to decide what tests are
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run on them, and (5) the right to destroy them (or have them destroyed in the case of
subjects wishing to withdraw from studies). September 2010 Office for Human Research
Protections guidance recommends that for human subjects’ research involving minimal risk
investigators may plan to retain and analyze data already collected at the time of withdrawal,
provided subjects are informed during the initial informed consent process of the policy of
the particular study regarding retention of data.28 The Office for Human Research
Protections guidance does not address withdrawal or destruction of specimens. One
investigator stated that ownership means “The ability to use these specimens for other
projects in the future” and, thus, concluded that he owned the specimens. Others were
reluctant to say that they owned the specimens but felt that the rights they had to the samples
implied they owned them. As one noted, “…I guess I do own them in the sense that I can
send them to somebody else with the right permission. I can destroy them. I can use it for
doing tests on them. So, I guess I do own them. More than anybody else owns them.”
Respondents who felt that the investigator owns, or ought to own, the specimens talked
about the significant responsibilities associated with caring for the specimens, including the
responsibility to ensure (1) their ethical management, (2) their proper maintenance and
security, and (3) the funding to store the specimens after the completion of the study. One
investigator, whose survey response was that both he and the contributors owned the
specimens, noted that “ownership means the authority to determine what happens to [the
specimens].” He remarked:
“First and foremost I think the donor owns the specimen …. The donor at any time
can ask to be removed and that is their right to ask for those samples to be
destroyed at any time that they want, so that’s why technically they hold the trump
card. The second person who is responsible is the principal investigator because …
you are the person who’s bearing the responsibility and the liability for the
possession of those samples.”
In reasoning through this sort of hierarchical order of ownership, he discusses rights
associated with the samples but then turns to responsibilities to justify why he, the principal
investigator, has an ownership claim. However, on further reasoning, he ultimately seems to
view his position as one of caretaking rather than ownership: “If I could only pick one
answer I would say the donors who contributed are the owner …. However, I do think that I
have an ethical obligation to care what happens to the samples.” Based on this reasoning, he
then argued strongly against placing ownership—that is, the rights and responsibilities
associated with the specimens—in the hands of the University—“some University entity just
takes charge of something that they don’t even really know about themselves. I think the
individual who donated should be the one who determines what happens.”
University as owner—In the follow-up interviews, those who had answered in the web
survey that the University owns the samples said that they chose this response because they
(1) believed there to be some legal precedent, (2) checked the consent form, or (3) made an
analogy to the University owning all supplies purchased with grant money. One respondent
who chose the University as owner on the survey still indicated some uncertainty regarding
ownership during the follow-up interview:
“Looking back … I struggled with this (question) a little bit from the standpoint of
I guess what was meant by ownership, and ultimately when you—any research
that’s done on this campus is not done in isolation of the University. The University
is ultimately responsible for I guess anything that’s done on this campus.”
The respondent added “I guess I really am unclear on who would own them … I guess I
would philosophically feel that the donors ultimately own the specimen from the standpoint
that they could withdraw consent at any time.”
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This respondent had also consulted the study consent form for specification of ownership
when he completed the survey, and referred to it during the interview, quoting: “Any blood,
body fluids, or tissue specimens obtained for the purpose of the study become the exclusive
property of the University.” He stated that the IRB had provided that specific clause and “…
as a PI with that standard language in, I felt that that must be an institutionalized decision.”
Other investigators who identified the University as the owner in the survey said they did so
with reluctance, typically due to their perceptions of their own close relationship to the
samples or of the contributors’ rights to have the samples destroyed. In response to “what
makes someone or some organization the owner of the specimens?” one investigator
described the conundrum this way:
“… we’ve had a lot of discussions around this, and I don’t even know. I mean one
day it’s one thing, and one day it’s the other. I guess if you’re at liberty to distribute
it and manage it, then I think you’re probably owning it… We are the ones who
ship it out and transfer it to other people and decide who legitimately should get it,
and I think you pretty much own it then. I mean the institution that you work within
I guess owns it because they’re providing the infrastructure for all those things. The
support of the staff and the finances for freezers and the whatever, without which
you wouldn’t be owning anything.”
Another investigator who answered the survey by stating that the University owns the
samples added an additional owner during the interview, “So I think in my verbal response I
would broaden my single answer to say that the co-PIs own—that we own the sample.”
Alternative model?—Like the aforementioned investigator who struggled with his sense
of sample ownership, some investigators who acknowledged that they did not own the
samples suggested an alternative relationship more in keeping with a stewardship model,
which takes into account their responsibility to manage the specimens properly. One
investigator affirmed that the University owns the samples but added that he is “the keeper.”
Another stated, “I’m the steward. It’s a national resource or a University resource. Kind of
both, isn’t it? But I don’t own it. I have a responsibility to manage it properly.” Finally, a
respondent who indicated in the survey that he did not know who or what owned the
specimens reasoned through the implications of ownership during the interview in this way:
“If I were assigned ownership of a collection of DNA samples, and I was killed,
then there would be no owner, right? I mean then the samples would be subject to
who knows what. So maybe the word owner is inappropriate. Maybe you should
call them the custodian…. Because that suggests some level of responsibility.”
Retention of specimens
Most investigators acknowledged that they had not thought about ownership of samples
before our web survey and interviews. However, all claimed that the issue is important to
understand as conflicts over ownership could impact their research work. The longer
specimens are retained, the more likely such conflicts are to occur, as researchers move to
new institutions, investigate new topics using the same specimens and data, share or
combine their specimens with other collections, and make decisions about sample storage
and destruction.
We asked survey respondents, “What will your research team do with some or all the
specimens after this project is completed? (Check all that apply)” (Table 4). Although some
respondents did not know (n = 11) or could not select a single category (n = 8), most
responded that the research team would keep specimens, either permanently (N = 17) or for
an as yet undetermined period (N = 29). Follow-up interviews explored investigators’
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decision-making process and perceptions of the advantages and disadvantages of retaining
specimens, topics investigators found more familiar than ownership. Investigators described
the value of retaining specimens in terms of the “infinite flexibility” they provided for future
research, arguing that they would “never learn all they need to know and so [wouldn’t] need
this stuff anymore.” For many, keeping specimens permanently or for a very long period
was presumed, as “the default position,” rather than formally decided: “You collect them
because you expect they’ll serve some useful purpose—that presumption never goes away.”
Respondents did describe conditions under which samples would be destroyed, such as
when requested by the contributor or when their research focus changed, and they described
the heavy financial burdens related to maintaining and tracking specimens, costs often not
covered by initial funders. Still, after weighing the burdens of keeping specimens versus
destroying them, they seemed to always conclude that keeping them is more advantageous:
“You would feel terrible if you had these precious specimens, and then destroyed them, and
then read a paper in the literature that you could easily have tested with your specimens, and
they’re not there anymore.”
Little understanding of University policies
In the web survey, open-ended comments suggested uncertainty or potential problems
related to external policies about specimen ownership and retention. One survey participant
wrote: “There is an incredible lack of knowledge and guidance for PIs about this issue. If the
rules exist, nobody enforces them.” We asked follow-up interview respondents about their
awareness of and attitudes toward any policies related to ownership or retention of samples.
Respondents who thought there were University policies tended to abide by the policies—
whatever they thought the policies were; they relied on the IRB for guidance about policies
—again, whatever they thought that guidance was. Some respondents who had set a time to
destroy specimens (e.g., 10 years after the completion of the study) did so because they
thought it was required by the IRB. One, who reported that she was destroying her samples
at the completion of her study because she believed that the IRB would not allow her to keep
them, began to second guess her decision during the course of the interview. In fact, the
University’s IRB requires that investigators, in their applications for study approval,
describe their plans for disposition of identifiable data or specimens. However, no policy
determines what those plans should be, nor is there a policy dictating that plans be specified
in consent forms.
Investigators who planned to keep the specimens indefinitely or who did not know how long
they would keep the specimens generally did not reference University or IRB policies in the
matter; nor did the University and/or the IRB seem to be part of their decision-making
process. They assumed that if their IRB application was approved, then they were abiding
by University policies. One noted, “There are so many rules and regulations out there that
nobody can keep track of… I make the assumption that if I meet the IRB requirements and
the HIPAA requirements, that I’ve probably done all that’s reasonable.” Another
commented, “I think clearly the University has its policies that are expressed primarily
through the IRB, and the IRB takes into account state and federal laws about that. So I don’t
have to think about that directly because it’s included in what the IRB requires.”
Investigators felt similarly about informed consent documents: if the documents were
approved by the IRB, then their language must represent University policy. Consequently,
several investigators consulted their own consent forms for language pertaining to
ownership of the specimens to answer our survey question regarding ownership. Despite
this, investigators also interpreted consent forms to suit their purposes, as when one
investigator acknowledged that his consent form states that samples will be destroyed 10
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years after the completion of the study but then added, “Who knows how long the study is
going to last?” implying that there is actually great flexibility in determining when 10 years
is over.
DISCUSSION
Although researchers share a common view that their samples are “precious,” they do not
display a set of shared perceptions about specimen ownership, retention, and oversight.
Instead, investigators display widely divergent views on ownership of retained specimens,
often identifying more than one owner, and show little awareness of University policies. Our
interviews reveal the significant logistical and ethical implications associated with
uncertainty about ownership and the desire to retain specimens long term or indefinitely.
External funding opportunities for long-term proper maintenance and tracking of specimens
is virtually nonexistent. Instead, these responsibilities often end up falling on the institution.
Without proper funding, especially combined with the possibility that investigators’ research
interests may change or investigators may leave the university and their specimens behind,
institutional obligations are unclear.
What rights and responsibilities attach to these long-held samples? Property law typically
recognizes a “bundle of rights” associated with ownership. Rao29 highlights two of these
rights as important to the debate over the goals of property law in the context of legal
regulation of the human body—the right to control the property and the right to receive
compensation. Characterizing ownership and the terms of use for the owned property, are
critical issues for biospecimens, their associated data, and researchers who use them. Yassin
and colleagues.30 propose that “custodianship” is more appropriate to describe the role of
researchers and their institutions than “ownership.” Other scholars prefer a “stewardship”
model, similar to the role of a trustee.31 The hesitation many of the investigators in our
interviews exhibit about ownership suggests that custodianship and stewardship frameworks
deserve further exploration and development (see also discussion by Capron and
colleages12).
These distinctions between ownership, custodianship, and stewardship of the specimens, any
bundled set of rights to control or use them, and rights in commercial products that stem
from research uses all remain subject to considerable debate.29,32,33 Winickoff34 asserts that
“bioethics scholarship on biobank governance has comparatively ignored property in favor
of focusing on consent, IRBs, and privacy.” Some policy leaders even acknowledge
uncertainty regarding ownership: “The NCI has chosen to use the term ‘custodianship’
rather than ‘ownership’ in the context of human specimens because issues of ownership
have yet to be resolved effectively in statute, regulation, or case law.”35 Thus, definitional
tensions persist regarding ownership of biospecimens for research.
Our empirical exploration of these issues has a number of limitations. It is based on
interviews with investigators conducting genetic research with human samples in one US
research university and, thus, cannot be generalized to other institutions or types of research.
Despite attempts to systematically recruit respondents, selection bias may play a role in
those who agreed to participate in both the pilot and follow-up interviews and in the web
survey. Our questions may not have been appropriate for all study designs. For example,
individual investigators involved in multisite studies, or studies mandated to participate in
data sharing agreements, may be constrained in ownership or retention by external funding
requirements. There may be other unknown factors that affected respondents’ answers.
Finally, our data illuminate ethical questions surrounding the indefinite retention of samples
only as they relate to ownership, rather than subject protection (e.g., reconsenting subjects
for new research and preventing identification of research subjects).
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Despite these limitations, we have confidence in the themes revealed by our data. By using a
mixed method study design, we were able to assess the prevalence of intriguing results from
our pilot interviews and then follow-up on findings from the web survey. Exact numbers in
response categories will not generalize to other populations, but these themes resonate
throughout the data: (1) each data source revealed significant inconsistency in views about
who actually owns the specimens; (2) investigators desire to retain and store “precious
specimens” for “in-finite flexibility”; (3) norms of ownership are not seen by investigators
as officially codified in any transparent or mutually agreed-upon fashion. We suspect that
these findings are common among investigators in other academic institutions.
Although the ethical, legal, and social landscape of specimen ownership is still evolving, our
research findings have clear policy implications for the present. Those exercising direct
control over human research specimens should be better informed about policies regarding
ownership and retention and work nationally with interdisciplinary groups to explore the
concerns and needs of all stakeholders in the biobanking enterprise. Ideally, investigators
should have guidance regarding how to safeguard samples if there is a significant change in
oversight, such as a principal investigator moving to another institution or leaving research.
In an era of increasing pressure for investigators to deposit research specimens and data in
widely accessible repositories or databases, it is important to acknowledge and address the
ethical obligations investigators feel toward specimen contributors. In the absence of clearly
agreed-upon professional norms governing collection, use, ownership, and storage of human
biologic specimens, the rights of stakeholders and the proper conduct of research may be
impeded. Thus, further research is needed to assist in establishing and disseminating clear
and feasible guidelines for ownership and retention of genetic material and data.
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Ownership question from web survey. 1 We used “donor” in our web survey. We prefer the
term “specimen contributor” because of the inferences that come from the term donor, but
when we pilot tested the web survey with biomedical researchers, respondents were
confused by “specimen contributor” and urged us to use “donor” for clarity.
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Table 1
Participant characteristics within each study
Pilot interviews (%) Web survey (%) Follow-up interviews (%)
Highest degree
 MD 7 (50.00) 21 (26.25) 4 (33.33)
 PhD 5 (35.71) 38 (47.50) 7 (58.33)
 MD-PhD 2 (14.29) 3 (3.75) 1 (8.33)
 Othera 0 (0.00) 9 (11.25) 0 (0.00)
 Missing 0 (0.00) 9 (11.25) 0 (0.00)
Role in studyb
 PI/Co-PI 14 (100.00)c 33 (41.25) 9 (75.00)
 Coinvestigator 0 (0.00) 21 (26.25) 3 (25.00)
 Other team member 0 (0.00) 18 (22.50) 0 (0.00)
 Other role 0 (0.00) 8 (10.00) 0 (0.00)
Affiliation
 Medicine (Not asked) 48 (60.00) 7 (58.33)
 Dentistry 5 (6.25) 3 (25.00)
 Public health 8 (10.00) 1 (8.33)
 Other/unspecified 9 (11.25) 1 (8.33)
 Missing 10 (1.25) 0 (0.00)
Database size (number of individual donors)
 1–100 donors (Not asked) 25 (31.25) 3 (25.00)
 101–1000 donors 22 (27.50) 1 (8.33)
 1001–5000 donors 15 (18.75) 5 (41.67)
 >5000 donors 3 (3.75) 2 (16.67)
 Missing 15 (18.75) 1 (8.33)
Total 14 (100.00) 80 (100.00) 12 (100.00)
The values are represented as frequency (%). Percentages may not total to 100 due to rounding.
a
“Other” degree included RN, MS, MPH, and BS.
b
Or role with greatest responsibility for the study when more than one role is mentioned.
c
Participants in the pilot interviews were all PIs since the sample was taken from the CRISP database.
PI, Principal Investigator.
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Table 2
Perceptions of ownership of specimen collection
Web survey Follow-up interviews
One owner 40 (50.00) 4 (33.33)
Two or more owners 28 (35.00) 6 (50.00)
Do not know who owns 9 (11.25) 2 (16.67)
Missing 3 (3.75) 0 (0.00)
Total 80 (100.00) 12 (100.00)
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Table 3
Single and multiple owners according to web survey respondents (n = 68)
One owner (n =
40) Two owners (n = 15) Three owners (n = 9)
Four owners (n =








Investigator and donor (4)




Donor and registry (1)
Donor and university (1)
University and funder (1)
Two universities (1)
Three investigatorsa (2)




















Three or more investigators may be more accurate, as the survey allowed up to three investigators to be indicated.
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Table 4
Intentions to retain specimens
Web survey Follow-up Interviews
“We will destroy specimens at a specified time” 10 (12.99) 4 (33.33)
“We will return specimens to the organization from which we obtained them” 2 (2.60) 0 (0.00)
“We will keep specimens permanently” 17 (22.08) 3 (25.00)
“We will keep specimens, but have not decided for how long” 29 (37.66) 3 (25.00)
Not sure/do not know 11 (14.29) 1 (8.33)
Could not choose one categorya 8 (10.39) 1 (8.33)
Total 77 (100.00)b 12 (100.00)
a
Includes those who checked two categories (destroy and keep permanently [depends on consent addendum], destroy and keep but do not know
how long) and those who provided text answers only.
b
Three web survey respondents did not answer this question.
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